ANNUAL REPORT 2021
LUNDBECK
ANNUAL REPORT 2021
= CONTENTS
SUMMARY FOR
THE GROUP
2017-2021
CONTINUED
34/111
Definitions
Interest-bearing debt
Interest-bearing net cash
EBIT margin²
EBITDA
Return on equity²
Equity ratio²
Invested capital
Net debt
Net debt/EBITDA²
Earnings per share, basic (EPS)²
Earnings per share, diluted (DEPS)²
Cash flows from operating activities per share,
diluted²
Net asset value per share, diluted
Market capitalization²
Price/Earnings, diluted²
Price/Cash flows, diluted²
Price/Net asset value, diluted
Debt and financial instruments (including financial leases) carrying interest
Cash, bank balances and securities less interest-bearing debt
Profit from operations as a percentage of revenue
Profit before interest, tax, depreciation, amortization and gain on divestment of properties
Net profit/(loss) for the year as a percentage of shareholders' equity (average)
Shareholders' equity, year-end, as a percentage of total assets
Shareholders' equity, year-end, plus net interest-bearing debt
Interest bearing debt less cash, bank balances and securities
Net interest-bearing debt divided by EBITDA
Net profit/(loss) for the year divided by average number of shares, excl. treasury shares
Net profit/(loss) for the year divided by average number of shares, excl. treasury shares,
incl. warrants, fully diluted
Cash flows from operating activities divided by average number of shares, excl. treasury
shares, incl. warrants, fully diluted
Shareholder's equity, year-end, divided by number of shares, year-end, excl. treasury
shares, incl. warrants, fully diluted
Total number of shares, year-end, multiplied by the official price quoted on Nasdaq
Copenhagen, year-end
The official price quoted on Nasdaq Copenhagen, year-end, divided by earnings per
share, diluted
The official price quoted on Nasdaq Copenhagen, year-end, divided by cash flows from
operating activities per share, diluted
The official price quoted on Nasdaq Copenhagen, year-end, divided by net asset value
per share, diluted
EBITDA calculation (DKKm)
2021
2020
20191
2018¹
20171
EBIT
2,010
1,990
3,153
4,846
8,174
+ Depreciation, amortization and impairment losses
1,710
2,793
1,670
1,638
1,258
- Gain on divestment of properties recognized in other operating
expenses, net
(48)
(242)
EBITDA
3,720
4,783
4,823
6,436
9,190
1) 2017-2019 have been restated to reflect the reversal of an impairment loss on the RexultiⓇ product rights in 2017.
2) Definitions according to the Danish Finance Society's Recommendations & Financial Ratios.View entire presentation